Nathan C. Hall MD, PhD

Nathan C. Hall MD, PhD
Assoc ProfessorCollege of
432 Doan Hall 395 W 12th Avenue Columbus Ohio 43210
Phone:614-293-2788Fax: 614-293-9275
  • Experimental Therapeutics

General Research Interest

Dr. Hall’s research interests include state-of-the-art image processing, reconstruction and quantification methods, PET/CT, MRI/PET and SPECT/CT. Kinetic modeling with dynamic imaging is also an area of interest. The over goal is to better determine ways to increase the sensitivity, specificity and accuracy of molecular imaging.

Research Description

The main focus of Dr. Hall’s efforts involve utilizing molecular imaging techniques to improve the management and care of cancer patients. Projects involve improving quantification for therapy response assessment, as well as, developing imaging techniques for use in the intra and perioperative setting to improve the care and outcome of surgical oncology patients.

Transinstitutional Work

Transinstitutional efforts have led to research collaborations with the Department of Opthomology, Department of Surgery, Department of Pathology and the Ohio State College of Veterinary Medicine.  We have an interdisciplinary research project designed around intraoperative imaging for better localization as well as verification of resection and improvement of pathology sampling in surgical oncology patients that involves Radiology, Surgery and Pathology.  I am the Co-Advisor for a PhD student in Biophysics as well.

Current Publications

  • Blum KAComplete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival.Cancer 2/27/2014
  • Cohen JB, Hall NC, Ruppert AS, Jones JA, Porcu P, Baiocchi R, Christian BA, Penza S, Benson DM Jr, Flynn J, Andritsos LA, Devine SM, Blum KAAssociation of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma.Bone Marrow Transplant 48(9) 1212-7 9/1/2013
  • Marcinow AM, Hall N, Byrum E, Teknos TN, Old MO, Agrawal AUse of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study.JAMA Otolaryngol Head Neck Surg 139(9) 895-902 9/1/2013
  • Laperle KM, Kim DC, Hall NC, Bobbey A, Shen DH, Nagy R, Wakely Jr PE, Lehman A, Jarjoura D, Jhiang SMModulation of sodium/iodide symporter expression in the salivary gland.Thyroid 23(8) 1029-36 8/1/2013
  • Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DRComparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.Ann Surg Oncol 20(8) 2590-9 8/1/2013
  • Povoski SP, Hall NCRecognizing the role of surgical oncology and cancer imaging in the multidisciplinary approach to cancer: an important area of future scholarly growth for BMC Cancer.BMC Cancer 13 355 7/23/2013
  • Povoski SP, Chapman GJ, Murrey DA, Lee R, Martin EW, Hall NCIntraoperative detection of ¹⁸F-FDG-avid tissue sites using the increased probe counting efficiency of the K-alpha probe design and variance-based statistical analysis with the three-sigma criteria.BMC Cancer 13 98 3/4/2013
  • Povoski SP, Hall NC, Murrey DA Jr, Sharp DS, Hitchcock CL, Mojzisik CM, Bahnson EE, Knopp MV, Martin EW Jr, Bahnson RRMultimodal imaging and detection strategy with 124 I-labeled chimeric monoclonal antibody cG250 for accurate localization and confirmation of extent of disease during laparoscopic and open surgical resection of clear cell renal cell carcinoma.Surg Innov 20(1) 59-69 2/1/2013
  • Kostakoglu L, Schöder H, Johnson JL, Hall NC, Schwartz LH, Straus DJ, Lacasce AS, Jung SH, Bartlett NL, Canellos GP, Cheson BDInterim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?Leuk Lymphoma 53(11) 2143-50 11/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: